Citations 1
Outcomes of Second-Line (2L) Triplet+ Regimens in Patients with Relapsed/Refractory Multiple Myeloma (MM) Following Progression after First-Line (1L) Lenalidomide in the Connect® MM Disease Registry
Abonour, Rafat , Durie, Brian G.M. , Gasparetto, Cristina, Narang, Mohit , Omel, James, Rifkin, Robert M. , Terebelo, Howard R. , Toomey, Kathleen, Slaff, Samantha, Danforth, Dailan, Chung, Weiyuan, Anand, Jasmeet, Yu, Edward, Tang, Derek, Jagannath, Sundar, Lee, Hans C. , Ailawadhi, Sikander , Gasparetto, Cristina , Hardin, James W. , Wagner, Lynne I. , Jagannath, Sundar
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 13256-13258
